Back to search
FDAFDA · Food and drugs·Recall number D-0852-2026

Chlorthalidone Tablets, USP, 25 mg, 100 Tablets per bottle, Rx only, Manufactured by: Inventia Healthcare Limited. NDC: 64980-599-01

Published September 23, 2026 · Recall initiated: September 3, 2026

Summary

FDA records drug Class II recall D-0852-2026, published September 23, 2026 and initiated September 3, 2026. Recalling firm: Inventia Healthcare Limited; Status: Ongoing; Reported quantity: 13567 bottles; Lot: Batch # RISA24002; Exp Date: 04/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if CHLORTHALIDONE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
CHLORTHALIDONE
Manufacturer
Inventia Healthcare Limited
Distributor
U.S. Nationwide
UPC
0364980599108
Lot
Batch # RISA24002; Exp Date: 04/2027
Risk classification
Class II
Area (FDA)
drug
Country
India

Related recalls

Questions about this recall

Was Chlorthalidone Tablets, USP, 25 mg, 100 Tablets per bottle, Rx only, Manufactured by: Inventia Healthcare Limited. NDC: 64980-599-01 recalled?

Yes. FDA published recall D-0852-2026 on September 23, 2026. Reported hazard: Failed Dissolution Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: CHLORTHALIDONE. UPC: 0364980599108.